Breaking Finance News

Merck (ETR:MRK) stock price target increased to 109.00EUR, issued a research note today by Commerzbank AG

Boasting a price of 100.90EUR, Merck (ETR:MRK) traded -0.37% lower on the day. With the last close up 3.94% from the two hundred day average, compared with the S&P 500 Index which has increased 0.06% over the date range. Merck has recorded a 50-day average of 61.60EUR and a two hundred day average of 61.72EUR. Volume of trade was down over the average, with 8,531,370 shares of MRK changing hands under the typical 10,772,000

In a report released on 2/9/2017 Commerzbank AG increased the stock price target of Merck (ETR:MRK) to 109.00EUR indicating a potential upside of 0.08%.

On 2/08/2017, Commerzbank AG released a statement on Merck (ETR:MRK) bumped up the target price from 0.00EUR to 109.00EUR that suggested an upside of 0.08%.

Performance Chart

Merck (ETR:MRK)

With a total market value of 0 EUR, Merck has price-earnings ratio of 31.45 with a one year low of 49.24EUR and a one year high of 65.46EUR .

A total of 20 brokers have issued a report on the company. 2 brokers rating the stock a strong buy, 7 firms rating the stock a buy, 13 firms rating the stock a hold, 0 firms rating the company a underperform, and finally zero equity analysts rating the company a sell with a one year target of 61.60EUR.

Brief Synopsis On Merck (ETR:MRK)

Merck KGaA is a Germany-based company engaged in the pharmaceutical industry. The Company operates through four business segments: Merck Serono; Consumer Health; Merck Millipore, and Performance Materials. Within the Merck Serono division, the Company focuses on therapeutic areas and prescription drugs of chemical and biotechnological origin. The Consumer Health division comprises the over-the-counter products for preventive health care and self-treatment of minor ailments. The Merck Serono and Consumer Health divisions form together the Company's Pharmaceutical business sector. The Merck Millipore division comprises the activities of the Millipore Corporation. The Performance Materials division consists mainly of the Liquid Crystals and Pigments & Cosmetics business units. The Company operates through numerous subsidiaries, including Peer+ BV, AZ Electronic Materials (AZ), BioControl Systems Inc and Ormet Circuits Inc., a material supplier for the semiconductor industry.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.